Homepage

Glaukos Corporation

GKOS NYSE Categories PDF
Healthcare · Medical - Devices · United States · Updated May 11, 1:50pm
$133.79
Price
$7.9B
Market Cap
995
Employees
0.95
Beta
Thomas William Burns
CEO
Business Description

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.

Business History
Price Overview
Last updated: May 11, 2026 1:50pm (just now)
$133.79
+0.27 (+0.20%)
Day Range
$130.87 – $136.26
52-Week Range
$73.16 – $146.75
50-Day MA
$115.98
200-Day MA
$102.93
Volume
260,224.00
Analyst Price Targets
Low $135.00
Consensus $146.67
High $170.00
(45 analysts)
Share Structure
Outstanding 58,733,900.00
Float 56,111,196.00
Free Float 95.5%
High free float — 95.5% of shares trade freely, ~4.5% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-40.79
Stock Price: $133.79
EPS (Diluted): -3.28
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
9.84
Stock Price: $133.79
Total Equity: $656.16M
Shares: 57,190,000
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
-196.47
Market Cap: $7.86B
Total Debt: $35.77M
Cash: $90.81M
EBITDA: -$44.39M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$6.5B
Market Cap: $7.86B
Total Debt: $35.77M
Cash: $90.81M
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
77.5%
Gross Profit: $393.22M
Revenue: $507.44M
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
-17.1%
Operating Income: -$86.73M
Revenue: $507.44M
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
-37.0%
Net Income: -$187.69M
Revenue: $507.44M
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
-26.5%
Net Income: -$187.69M
Total Equity: $656.16M
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
-10.4%
Operating Income: -$86.73M
Tax Rate: 2.8%
Equity: $656.16M
Total Debt: $35.77M
Cash: $90.81M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
4.69
Current Assets: $474.98M
Current Liabilities: $101.28M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.05
Short-Term Debt: $0.00
Long-Term Debt: $35.77M
Total Debt: $35.77M
Total Equity: $656.16M
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$8.87
Revenue: $507.44M
Shares: 57,190,000
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$11.47
Total Equity: $656.16M
Shares: 57,190,000
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$-0.94
Operating CF: -$46.34M
CapEx: -$7.67M
Shares: 57,190,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $133.79
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$187.69M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares GKOS against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Metric 2021 2022 2023 2024 2025
Revenue $294.0M $282.9M $314.7M $383.5M $507.4M
Cost of Revenue $66.6M $69.0M $75.6M $94.0M $114.2M
Gross Profit $227.4M $213.9M $239.1M $289.5M $393.2M
Operating Expenses $260.3M $296.2M $367.8M $411.8M $479.9M
Operating Income -$32.9M -$82.3M -$128.7M -$122.4M -$86.7M
Net Income -$49.6M -$99.2M -$134.7M -$146.4M -$187.7M
EBITDA -$1.5M -$48.8M -$82.1M -$95.6M -$44.4M
EPS $-1.07 $-2.09 $-2.78 $-2.77 $-3.28
EPS (Diluted) — — — — —
Balance Sheet (Annual)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $100.7M $119.5M $93.5M $169.6M $90.8M
Total Current Assets $486.1M $443.9M $395.5M $449.8M $475.0M
Total Assets $1.1B $1.1B $940.4M $974.8M $893.5M
Current Liabilities $63.4M $72.4M $74.0M $75.1M $101.3M
Long-Term Debt $280.0M $281.4M $282.8M $0 $35.8M
Total Liabilities $541.7M $544.2M $478.6M $207.8M $237.3M
Total Equity $587.2M $530.0M $461.8M $766.9M $656.2M
Retained Earnings -$365.2M -$464.4M -$599.1M -$745.4M -$933.1M
Cash Flow (Annual)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $24.7M -$33.1M -$57.8M -$61.3M -$46.3M
Capital Expenditure -$47.8M -$30.3M -$20.2M -$6.3M -$7.7M
Free Cash Flow -$23.1M -$63.3M -$78.0M -$67.6M -$54.0M
Acquisitions (net) $3,000 $151,000 $0 $38,000 -$12.4M
Debt Repayment — — — — —
Dividends Paid — — — — —
Stock Buybacks $0 $0 $0 $0 $0
Net Change in Cash $4.1M $18.8M -$26.1M $76.2M -$111.3M
Analyst Estimates (Annual)
Metric 2027 2028 2029 2030
Revenue $796.3M
$778.3M – $809.6M
 $1.0B
$1.0B – $1.0B
 $1.3B
$1.3B – $1.4B
 $1.6B
$1.5B – $1.6B
EBITDA -$123.5M
-$125.5M – -$120.7M
 -$156.8M
-$156.8M – -$156.8M
 -$205.0M
-$210.3M – -$196.9M
 -$240.3M
-$246.6M – -$230.8M
Net Income $15.4M
$7.5M – $34.9M
 $92.5M
$47.0M – $134.4M
 $157.6M
$149.4M – $162.9M
 $264.8M
$251.1M – $273.7M
EPS — — — —
Growth Trends (YoY %)
Metric 2022 2023 2024 2025
Revenue Growth -3.8% +11.3% +21.9% +32.3%
Gross Profit Growth -5.9% +11.8% +21.0% +35.8%
Operating Income Growth -150.4% -56.4% +4.9% +29.1%
Net Income Growth -100.0% -35.8% -8.7% -28.2%
EBITDA Growth -3,208.2% -68.4% -16.5% +53.6%
Insider Trading (Recent)
Date Insider Type Shares Price Value
2026-04-30 Thurman Alex R. M-Exempt 10,000.00 $38.68 $386,800
2026-04-30 Thurman Alex R. S-Sale 10,000.00 $140.00 $1.4M
2026-04-30 Thurman Alex R. M-Exempt 10,000.00 $38.68 $386,800
2026-05-01 Gilliam Joseph E S-Sale 19,573.00 $143.54 $2.8M
2026-05-01 WEN LEANA S-Sale 1,700.00 $143.35 $243,695
2026-04-10 Navratil Tomas S-Sale 1,237.00 $116.72 $144,383
2026-04-10 Navratil Tomas S-Sale 210.00 $117.45 $24,665
2026-04-10 Navratil Tomas S-Sale 614.00 $119.35 $73,281
2026-04-10 Navratil Tomas S-Sale 32.00 $120.23 $3,847
2026-04-02 Navratil Tomas F-InKind 1,146.00 $109.60 $125,602
2026-04-02 Navratil Tomas F-InKind 1,831.00 $109.60 $200,678
2026-04-02 Thurman Alex R. F-InKind 1,589.00 $109.60 $174,154
2026-04-02 Gilliam Joseph E F-InKind 3,169.00 $109.60 $347,322
2026-04-01 Burns Thomas William G-Gift 180,308.00 $0.00 $0
2026-04-01 Burns Thomas William G-Gift 180,308.00 $0.00 $0
2026-04-02 Burns Thomas William F-InKind 2,469.00 $109.60 $270,602
2026-04-02 Burns Thomas William F-InKind 7,468.00 $109.60 $818,493
2026-03-31 Navratil Tomas F-InKind 5,798.00 $109.60 $635,461
2026-03-25 Burns Thomas William A-Award 14,184.00 $0.00 $0
2026-03-25 Burns Thomas William A-Award 9,380.00 $0.00 $0
Community AI Feedback
Sign in to Contribute
No community reviews yet for GKOS. Be the first — export the analysis to your AI and contribute back.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27